Metrics
- Price
- $11.95
- Market Cap $M
- 258
- Rel Volume
- 1.29
- Vol Up 2W
- 55.60%
- Vol Trend 2W
- +16.10%
- 1D
- +3.02%
- 1W
- -9.74%
- 1M
- +13.49%
- 1M Slope
- +20.92%
- 6M Range
- 261.37%
- Score
- 71.1
- Sharp
- -4.1
Volume
Profile
Cybin is a biopharmaceutical company developing psychedelic-based treatments for mental health disorders and related conditions.
Biotech
Pharmaceuticals